The monoclonal antitoxin antibodies (actoxumab-bezlotoxumab) treatment facilitates normalization of the gut microbiota of mice with Clostridium difficile infection

  1. Džunková, M.
  2. D'Auria, G.
  3. Xu, H.
  4. Huang, J.
  5. Duan, Y.
  6. Moya, A.
  7. Kelly, C.P.
  8. Chen, X.
Revista:
Frontiers in Cellular and Infection Microbiology

ISSN: 2235-2988

Any de publicació: 2016

Volum: 6

Número: OCT

Tipus: Article

DOI: 10.3389/FCIMB.2016.00119 GOOGLE SCHOLAR lock_openAccés obert editor